Nevertheless, comparing LCNEC with SCLC and low-grade neuroendocrine tumors, LCNEC exhibits a higher PD-L1 positivity, which is worth further investigations for potential immunotherapy application. The gene discussed is CD274; the disease is large cell neuroendocrine carcinoma.